Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Arthralgia 5Neoplasm Metastasis 3Patient Compliance 2Obesity 2Neoplasms 2Advanced Breast Cancer 2Vitamin D Deficiency 1Recurrence 1Pain 1Osteoporosis 1Nutrition Disorders 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fractures, Bone 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Cancer Organoids 1Arthritis 1

Interventions

abemaciclib 2Blood Specimen Collection 2ribociclib 1palbociclib 1Watchful Waiting 1Surgical Procedures, Operative 1Letrozole 1Lead 1High-Energy Shock Waves 1Genotype 1Fulvestrant 1Bone Density 1Body Height 1Blood Pressure 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Diseases × Anastrozole × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡